SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amnesia D000647 12 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Arthritis D001168 41 associated lipids
Body Weight D001835 333 associated lipids
Burns D002056 34 associated lipids
Cataract D002386 34 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Coronary Disease D003327 70 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Dyspepsia D004415 5 associated lipids
Endometriosis D004715 29 associated lipids
Fatty Liver D005234 48 associated lipids
Fever D005334 35 associated lipids
Heart Failure D006333 36 associated lipids
Hemolysis D006461 131 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hypertension D006973 115 associated lipids
Hypertension, Renovascular D006978 10 associated lipids
Inflammation D007249 119 associated lipids
Insulin Resistance D007333 99 associated lipids
Lead Poisoning D007855 4 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Memory Disorders D008569 33 associated lipids
Parkinson Disease D010300 53 associated lipids
Urinary Incontinence D014549 4 associated lipids
Reperfusion Injury D015427 65 associated lipids
Glucose Intolerance D018149 13 associated lipids
Alcohol-Related Disorders D019973 3 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Brain Infarction D020520 17 associated lipids
Stroke D020521 32 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Severino P et al. Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery. 2012 J Drug Deliv pmid:22175030
Zhang H et al. A model for the shuttle motions of puerarin and daidzin inside the cavity of β-cyclodextrin in aqueous acetic acid: insights from molecular dynamics simulations. 2012 J Mol Model pmid:21523551
Fan R et al. Ethnopharmacokinetic- and activity-guided isolation of a new antidepressive compound from fructus aurantii found in the traditional chinese medicine chaihu-shugan-san: a new approach and its application. 2012 Evid Based Complement Alternat Med pmid:22454671
Wang Q et al. [Distribution of puerarin contained in Zige freeze-dried powder injection in rat liver and kidney]. 2012 Zhongguo Zhong Yao Za Zhi pmid:22994007
Wang Y et al. Formulation and pharmacokinetics evaluation of puerarin nanocrystals for intravenous delivery. 2012 J Nanosci Nanotechnol pmid:22962724
Tiyasatkulkovit W et al. Upregulation of osteoblastic differentiation marker mRNA expression in osteoblast-like UMR106 cells by puerarin and phytoestrogens from Pueraria mirifica. 2012 Phytomedicine pmid:22951392
Wang PP et al. Puerarin stimulates osteoblasts differentiation and bone formation through estrogen receptor, p38 MAPK, and Wnt/β-catenin pathways. 2012 J Asian Nat Prod Res pmid:22917468
Saha P et al. Puerarin, a selective oestrogen receptor modulator, disrupts pregnancy in rats at pre-implantation stage. 2012 Reproduction pmid:22919047
Fan JP et al. Optimization of ionic liquid based ultrasonic assisted extraction of puerarin from Radix Puerariae Lobatae by response surface methodology. 2012 Food Chem pmid:22980805
Liu CM et al. Puerarin protects rat kidney from lead-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. 2012 Toxicol. Appl. Pharmacol. pmid:22172631
Luo ZK et al. [A clinical efficacy and safety study on coronary heart disease and angina treatment with Puerarin Injection]. 2012 Zhonghua Liu Xing Bing Xue Za Zhi pmid:22883272
Zeng X et al. Enhanced adsorption of puerarin onto a novel hydrophilic and polar modified post-crosslinked resin from aqueous solution. 2012 J Colloid Interface Sci pmid:22878002
Michihara S et al. Puerarin exerted anti-osteoporotic action independent of estrogen receptor-mediated pathway. 2012 J. Nutr. Sci. Vitaminol. pmid:22878391
Zhang BS et al. [Cellular absorption of the active ingredients in different compatibilities of gegenqinlian decoction in human intestinal Caco-2 cells]. 2012 Zhong Yao Cai pmid:23451503
An R et al. [Intestinal absorption of different combinations of active compounds from Gegenqinlian decoction by rat single pass intestinal perfusion in situ]. 2012 Yao Xue Xue Bao pmid:23460978
Chen F et al. Puerarin enhances superoxide dismutase activity and inhibits RAGE and VEGF expression in retinas of STZ-induced early diabetic rats. 2012 Asian Pac J Trop Med pmid:23146804
Prasain JK et al. The Chinese Pueraria root extract (Pueraria lobata) ameliorates impaired glucose and lipid metabolism in obese mice. 2012 Phytomedicine pmid:23123226
Chen R et al. Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-β1 expression. 2012 J. Nutr. Biochem. pmid:22079205
Han JQ et al. [Effects of puerarin on the neurocyte apoptosis and p-Akt (Ser473) expressions in rats with cerebral ischemia/reperfusion injury]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:23173255
Liang XL et al. Transport properties of puerarin and effect of Radix Angelicae Dahuricae extract on the transport of puerarin in Caco-2 cell model. 2012 J Ethnopharmacol pmid:23085309
Zhang Q et al. Puerarin protects differentiated PC12 cells from Hâ‚‚Oâ‚‚-induced apoptosis through the PI3K/Akt signalling pathway. 2012 Cell Biol. Int. pmid:22126839
Ford AP In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization. 2012 Purinergic Signal. pmid:22095157
Jin SE et al. Anti-inflammatory and antioxidant activities of constituents isolated from Pueraria lobata roots. 2012 Arch. Pharm. Res. pmid:22644850
Deng Y et al. [Effect of phenformin hydrochloride on pharmacokinetics of puerarin in rats]. 2012 Zhongguo Zhong Yao Za Zhi pmid:23270242
Zheng GH et al. Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention. 2012 Evid Based Complement Alternat Med pmid:22454659
Wu Y et al. Optimisation of ultrasound-assisted extraction of puerarin and total isoflavones from Puerariae Lobatae Radix (Pueraria lobata (Wild.) Ohwi) with response surface methodology. 2012 Sep-Oct Phytochem Anal pmid:22259187
Xie J et al. Improvement in solubility and bioavailability of puerarin by mechanochemical preparation. 2013 Drug Dev Ind Pharm pmid:22591175
Luo CF et al. Metabolic profile of puerarin in rats after intragastric administration of puerarin solid lipid nanoparticles. 2013 Int J Nanomedicine pmid:23486407
Cao L et al. Pharmacokinetics of puerarin in pregnant rats at different stages of gestation after oral administration. 2013 Fitoterapia pmid:23500385
Guo C et al. Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway. 2013 Food Chem. Toxicol. pmid:23500774
Liu CM et al. Protective effect of puerarin on lead-induced mouse cognitive impairment via altering activities of acetyl cholinesterase, monoamine oxidase and nitric oxide synthase. 2013 Environ. Toxicol. Pharmacol. pmid:23501611
Cheng M et al. Puerarin accelerates re-endothelialization in a carotid arterial injury model: impact on vasodilator concentration and vascular cell functions. 2013 J. Cardiovasc. Pharmacol. pmid:23792702
Xu L et al. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect. 2013 Phytomedicine pmid:23856441
Li R et al. Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats. 2013 Brain Res. pmid:23603411
Zhang E et al. [Formulation optimization and drug release in vitro of membrane controlled tablets of puerarin inclusion compound]. 2013 Zhongguo Zhong Yao Za Zhi pmid:23596875
Li N et al. Determination of glibenclamide and puerarin in rat plasma by UPLC-MS/MS: application to their pharmacokinetic interaction study. 2013 Talanta pmid:23597896
Wang Y et al. Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/Akt activation. 2013 Phytomedicine pmid:23639192
Chen F et al. Puerarin-induced immune hemolytic anemia. 2013 Int. J. Hematol. pmid:23661032
Cao WL et al. [Effect of puerarin on hemorheology and pulmonary pressure in rat pneumo-cardiac disease]. 2013 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:23662397
Huang ZG et al. [Effect of puerarin combined with felodipine on mRNA and protein expression of apelin and APJ in renovascular hypertensive rat]. 2013 Zhongguo Zhong Yao Za Zhi pmid:23668014
Zhang Y et al. Effects of puerarin on cholinergic enzymes in the brain of ovariectomized guinea pigs. 2013 Int. J. Neurosci. pmid:23668913
Chen X et al. Puerarin improves metabolic function leading to hepatoprotective effects in chronic alcohol-induced liver injury in rats. 2013 Phytomedicine pmid:23669266
Wang Q et al. Magnetic solid-phase extraction and determination of puerarin in rat plasma using C(18)-functionalized magnetic silica nanoparticles by high performance liquid chromatography. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23246846
Peng JH et al. Puerarin ameliorates experimental alcoholic liver injury by inhibition of endotoxin gut leakage, Kupffer cell activation, and endotoxin receptors expression. 2013 J. Pharmacol. Exp. Ther. pmid:23277536
Nakamura K et al. Enzymatic cleavage of the C-glucosidic bond of puerarin by three proteins, Mn(2+), and oxidized form of nicotinamide adenine dinucleotide. 2013 Biol. Pharm. Bull. pmid:23328408
Tao HQ et al. HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in rats. 2013 Naunyn Schmiedebergs Arch. Pharmacol. pmid:23192284
Yin R et al. UFLC-MS/MS method for simultaneous determination of luteolin-7-O-gentiobioside, luteolin-7-O-β-D-glucoside and luteolin-7-O-β-D-glucuronide in beagle dog plasma and its application to a pharmacokinetic study after administration of traditional Chinese medicinal preparation: Kudiezi injection. 2013 J Pharm Biomed Anal pmid:23146236
Li R et al. Puerarin mediates hepatoprotection against CCl4-induced hepatic fibrosis rats through attenuation of inflammation response and amelioration of metabolic function. 2013 Food Chem. Toxicol. pmid:23146695
Zou Y et al. Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3β/Nrf2 signaling pathway. 2013 Free Radic. Res. pmid:23088308
Wang Y et al. In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity. 2013 Int J Pharm pmid:23089583
Zhang J et al. Effects of puerarin on the inflammatory role of burn-related procedural pain mediated by P2X(7) receptors. 2013 Burns pmid:23044342
Bai S et al. Effects of felodipine combined with puerarin on ACE2-Ang (1-7)-Mas axis in renovascular hypertensive rat. 2013 Regul. Pept. pmid:23523569
Tian F et al. The neuroprotective mechanism of puerarin treatment of acute spinal cord injury in rats. 2013 Neurosci. Lett. pmid:23570727
Li R et al. Puerarin attenuates neuronal degeneration in the substantia nigra of 6-OHDA-lesioned rats through regulating BDNF expression and activating the Nrf2/ARE signaling pathway. 2013 Brain Res. pmid:23747813
Li R et al. Puerarin, isolated from Kudzu root (Willd.), attenuates hepatocellular cytotoxicity and regulates the GSK-3β/NF-κB pathway for exerting the hepatoprotection against chronic alcohol-induced liver injury in rats. 2013 Int. Immunopharmacol. pmid:23751897
Liu X et al. Pharmacokinetic comparisons of puerarin, daidzin and the glucuronide metabolite of puerarin after administration of total flavonoid from Gegen alone and total flavonoid from Gegen combined with total saponin from Sanqi in rats under different physiological states. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23774247
Wong KH et al. Differentiation of Pueraria lobata and Pueraria thomsonii using partial least square discriminant analysis (PLS-DA). 2013 J Pharm Biomed Anal pmid:23777642
Xia DZ et al. Hepatoprotective activity of puerarin against carbon tetrachloride-induced injuries in rats: a randomized controlled trial. 2013 Food Chem. Toxicol. pmid:23764356
Wang L et al. Protective effects of puerarin on experimental chronic lead nephrotoxicity in immature female rats. 2013 Hum Exp Toxicol pmid:23315276
Wu K et al. Anti-diabetic effects of puerarin, isolated from Pueraria lobata (Willd.), on streptozotocin-diabetogenic mice through promoting insulin expression and ameliorating metabolic function. 2013 Food Chem. Toxicol. pmid:23927877
Wu X et al. Isolation, identification and pharmacokinetic analysis of fructosyl puerarins from enzymatic glycosylation. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23948238
Cheng Y et al. Effects of puerarin on cardiac differentiation and ventricular specialization of murine embryonic stem cells. 2013 Cell. Physiol. Biochem. pmid:24080853
Zhao LX et al. The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury. 2013 Biol. Pharm. Bull. pmid:23902970
Ji M et al. Puerarin suppresses proliferation of endometriotic stromal cells in part via differential recruitment of nuclear receptor coregulators to estrogen receptor-α. 2013 J. Steroid Biochem. Mol. Biol. pmid:23907019
Tu L et al. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat. 2013 Int J Pharm pmid:24120729
Cui YH et al. [Adsorption and isolation of macroporous resin for three isoflavonoids from puerariae lobatae radix]. 2013 Zhong Yao Cai pmid:24134015
Singh AK et al. Anti-inflammatory potency of nano-formulated puerarin and curcumin in rats subjected to the lipopolysaccharide-induced inflammation. 2013 J Med Food pmid:24138167
Jiang L et al. Simultaneous determination of gastrodin and puerarin in rat plasma by HPLC and the application to their interaction on pharmacokinetics. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23314488
Liu AC et al. LC-MS/MS method for the determination of a new puerarin derivative and its application in pharmacokinetic studies in rats. 2013 Chin J Nat Med pmid:24359785
Zhu H et al. Effect of puerarin on matrix metalloproteinase-2 in human fetal scleral fibroblasts treated with low frequency electromagnetic fields. 2013 J Tradit Chin Med pmid:24660593
Tang TT et al. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach. 2013 Int J Nanomedicine pmid:24277986
Ji O et al. [Effect of flavonoids of puerarin on the proliferation and apoptosis of retinoic acid resistant acute promyelocytic leukemia cell line NB4-R1 cells]. 2013 Zhonghua Xue Ye Xue Za Zhi pmid:23688762
Gu L et al. Polyamidomine dendrimers: an excellent drug carrier for improving the solubility and bioavailability of puerarin. 2013 Sep-Oct Pharm Dev Technol pmid:22303809
Zhu X et al. The effect of puerarin against IL-1β-mediated leukostasis and apoptosis in retinal capillary endothelial cells (TR-iBRB2). 2014 Mol. Vis. pmid:25593509
Fu R et al. Digital gene expression analysis of the pathogenesis and therapeutic mechanisms of ligustrazine and puerarin in rat atherosclerosis. 2014 Gene pmid:25218235
Kim MH et al. Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease. 2014 Planta Med. pmid:25210998
Wang J et al. Synergistic effects of puerarin combined with 5-fluorouracil on esophageal cancer. 2014 Mol Med Rep pmid:25189132
Zhang WG et al. Puerarin inhibits growth and induces apoptosis in SMMC-7721 hepatocellular carcinoma cells. 2014 Mol Med Rep pmid:25175767
Wang C et al. Puerarin protects against β-amyloid-induced microglia apoptosis via a PI3K-dependent signaling pathway. 2014 Neurochem. Res. pmid:25173404
Xie N et al. Puerarin protects hippocampal neurons against cell death in pilocarpine-induced seizures through antioxidant and anti-apoptotic mechanisms. 2014 Cell. Mol. Neurobiol. pmid:25151533
Maji AK et al. Pueraria tuberosa: a review on its phytochemical and therapeutic potential. 2014 Nat. Prod. Res. pmid:24980468
Ma JQ et al. Puerarin ameliorates carbon tetrachloride-induced oxidative DNA damage and inflammation in mouse kidney through ERK/Nrf2/ARE pathway. 2014 Food Chem. Toxicol. pmid:24975872
Wang C et al. The proliferation, differentiation, and mineralization effects of puerarin on osteoblasts in vitro. 2014 Chin J Nat Med pmid:24969524
Wei SY et al. Progress on the pharmacological research of puerarin: a review. 2014 Chin J Nat Med pmid:24969520
Park WS et al. Anti-graying effect of the extract of Pueraria thunbergiana via upregulation of cAMP/MITF-M signaling pathway. 2014 J. Dermatol. Sci. pmid:24924521
Yu P et al. Determination of puerarin in rat plasma using PEGylated magnetic carbon nanotubes by high performance liquid chromatography. 2014 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:24768919
Kim SB et al. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism. 2014 Planta Med. pmid:24710899
Liu Y et al. Induction of adhesion molecule expression in co-culture of human bronchial epithelial cells and neutrophils suppressed by puerarin via down-regulating p38 mitogen-activated protein kinase and nuclear factor κB pathways. 2014 Chin J Integr Med pmid:24122632
Chen YG et al. Metabolic differentiations of Pueraria lobata and Pueraria thomsonii using ¹H NMR spectroscopy and multivariate statistical analysis. 2014 J Pharm Biomed Anal pmid:23746990
Zhu G et al. Neuroprotective effects of puerarin on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease model in mice. 2014 Phytother Res pmid:23512787
Zhou A et al. Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats. 2014 Pharm Dev Technol pmid:23978005
Wang JW et al. Puerarin ameliorates oxidative stress in a rodent model of traumatic brain injury. 2014 J. Surg. Res. pmid:24079811
Zhong Y et al. Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats. 2014 PLoS ONE pmid:24454919
Bao MH et al. Puerarin protects endothelial cells from oxidized low density lipoprotein induced injuries via the suppression of LOX-1 and induction of eNOS. 2014 Can. J. Physiol. Pharmacol. pmid:24708212
Mahdy HM et al. The anti-apoptotic and anti-inflammatory properties of puerarin attenuate 3-nitropropionic-acid induced neurotoxicity in rats. 2014 Can. J. Physiol. Pharmacol. pmid:24593790
Wang XC et al. [Effect of chaperone-mediated autophagy in MPP(+) -induced SH-SY5Y cells and interventional effect of puerarin]. 2014 Zhongguo Zhong Yao Za Zhi pmid:24754178
Qu H et al. Development of an enzyme-linked immunosorbent assay based on anti-puerarin monoclonal antibody and its applications. 2014 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:24583873
Liao ZG et al. Transport properties of puerarin and effect of extract of Radix Angelicae dahuricae on puerarin intestinal absorption using in situ and in vitro models. 2014 Phytother Res pmid:24756954
Lu Q et al. Puerarin attenuates calcification of vascular smooth muscle cells. 2014 Am. J. Chin. Med. pmid:24707866
Wang Y et al. Simultaneous determination of four components in Baige capsule by HPLC: application to pharmacokinetics and tissue distribution of normal and middle cerebral artery occlusion rats. 2014 Biomed. Chromatogr. pmid:24122939